Table 2.
Variables | Odds Ratio | 95%CI | P |
---|---|---|---|
Nationality | |||
Saudi | 0.483 | 0.305–0.766 | 0.002 |
Non- Saudi | 2.069 | 1.306–3.278 | 0.002 |
Age Groups | |||
<40 years | 1.232 | 0.593–2.560 | 0.575 |
40–60 years | 0.607 | 0.377–0.977 | 0.040 |
>60 years | 1.672 | 0.977–2.860 | 0.061 |
NACT | |||
Yes | 1.616 | 1.008–2.593 | 0.046 |
No | 0.619 | 0.386–0.993 | 0.046 |
Laterality | |||
Right | 1.042 | 0.669–1.622 | 0.856 |
Left | 0.960 | 0.616–1.495 | 0.856 |
Tumor Focality | |||
Unifocal | 0.391 | 0.233–0.657 | 0.0001 |
Multifocal | 2.557 | 1.522–4.295 | 0.0001 |
Tumor Centricity | |||
Unicentric | 0.241 | 0.124–0.467 | 0.0001 |
Multicentric | 4.155 | 2.142–8.061 | 0.0001 |
Tumor Size (cm) | 1.247 | 1.115–1.395 | 0.0001 |
Tumor Size Groups | |||
<2 cm | 0.623 | 0.384–1.012 | 0.056 |
2–5 cm | 0.936 | 0.601–1.456 | 0.768 |
>5 cm | 2.124 | 1.166–3.868 | 0.014 |
Tumor Stage | |||
0 | 0.691 | 0.327–1.459 | 0.333 |
IA | 0.259 | 0.126–0.529 | 0.0001 |
IIA | 0.945 | 0.555–1.608 | 0.833 |
IIB | 0.553 | 0.305–1.003 | 0.051 |
IIIA | 2.753 | 1.360–5.575 | 0.005 |
IIIB | 3.897 | 1.317–11.528 | 0.014 |
IIIC | 2.060 | 0.900–4.714 | 0.087 |
Tumor Grade | |||
I | 1.017 | 0.569–1.818 | 0.955 |
II | 0.980 | 0.620–1.549 | 0.933 |
III | 0.994 | 0.632–1.565 | 0.981 |
Unknown | 1.059 | 0.431–2.600 | 0.900 |
Positive Estrogen Receptor Status | 1.422 | 0.878–2.302 | 0.163 |
Positive Progesterone Receptor Status | 1.145 | 0.723–1.813 | 0.656 |
Positive HER2 Receptor Status | 1.963 | 1.181–3.264 | 0.009 |
Triple Negative Tumors | 2.109 | 1.195–3.723 | 0.010 |
Doing MRIa | 0.729 | 0.426–1.247 | 0.240 |
MRIaFinding | |||
Unilateral Malignant Findings | 0.855 | 0.475–1.539 | 0.602 |
Bilateral Malignant Findings | 1.283 | 0.607–2.709 | 0.514 |
Benign Findings | 1.001 | 0.448–2.235 | 0.999 |
MRI = magnetic resonance imaging.